Dermatology NewsExpert Highlights Biologics in the Pipeline for Atopic DermatitisJanuary 4, 2024Atopic DermatitisPediatrics
Dermatology NewsUS Dermatologic Drug Approvals Rose Between 2012 and 2022January 4, 2024Medical DermatologyAcneAtopic DermatitisAutoimmune DiseasesHair & NailsMelasmaRosacea
Dermatology NewsWhich Tools Are Best to Streamline In-Office Assessments of Eczema Patients?December 29, 2023Atopic Dermatitis
Experimental Topical Drug Shows Promise for Atopic Dermatitis and Plaque PsoriasisDecember 28, 2023Atopic DermatitisPsoriasis
Expert Frames Factors to Consider Among Atopic Dermatitis Treatment OptionsDecember 27, 2023Atopic Dermatitis
Dermatology News‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib TrialsDecember 26, 2023Atopic DermatitisPediatrics
What’s the Real Prevalence of Conjunctivitis in AD Patients Treated With Dupilumab?December 22, 2023Atopic Dermatitis
Dermatology News‘Real-World’ Registry Study of Upadacitinib Supports Clinical Trial DataDecember 22, 2023Atopic Dermatitis
Dermatology NewsParadoxical Eczema Risk Low With Biologic Psoriasis TreatmentsDecember 20, 2023PsoriasisPsoriatic ArthritisAtopic Dermatitis
Dermatology NewsHow does lebrikizumab perform across different racial and ethnic subgroups?December 15, 2023Atopic DermatitisDiversity in MedicinePediatrics
Dermatology NewsAdequate disease control elusive for many patients on systemic AD therapies, study findsDecember 14, 2023Atopic Dermatitis
Dermatology NewsTape strips detect hidradenitis suppurativa biomarkers, novel study showsDecember 8, 2023Medical DermatologyPsoriasisAtopic Dermatitis
Association Between Atopic Dermatitis and Chronic Obstructive Pulmonary Disease Among US Adults in the 1999-2006 NHANES SurveyDecember 4, 2023Atopic Dermatitis
Dermatology NewsLow-dose methotrexate carries higher risk for older patients with CKDNovember 28, 2023Atopic DermatitisPsoriasis
Dermatology NewsTapinarof effective for AD in patients as young as 2 yearsNovember 27, 2023Atopic DermatitisPediatrics
